DURECT Corporation to Participate in Upcoming Healthcare Conferences
Cupertino, CA-
June 06, 2008
CUPERTINO, CA, June 6, 2008/ PRNewswire-First Call via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at three upcoming life sciences conferences in New York, NY.
- Needham & Company’s Biotechnology and Medical Technology Conference on Thursday, June 12th at 11:30 a.m. EDT.
- Leerink Swann’s Pain Roundtable Conference, on Monday, June 23rd at 12:45 p..m. EDT.
- Jefferies’ 2nd Annual Healthcare Conference on Thursday, June 26th at 10:45 a.m. EDT.
A live audio webcast of the presentations will be available by accessing DURECT’s homepage at http://www.durect.com and clicking “Investor Relations.” If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation CONTACT: Matthew J. Hogan, Chief Financial Officer, +1-408-777-4936
|
|
